Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2003
07/31/2003WO2002101005A3 A g-protein coupled receptor and uses therefor
07/31/2003WO2002100408A3 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
07/31/2003WO2002099042A3 Cads as modifiers of the p53 pathway and methods of use
07/31/2003WO2002096192A3 Process of producing environmentally safe transgenic organisms
07/31/2003WO2002094202B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
07/31/2003WO2002090377A3 Peptides that bind to dna and inhibit dna replication, and methods of use
07/31/2003WO2002090372A3 Products containing charged biomaterials and method for the preparation thereof
07/31/2003WO2002088363A3 Regulation of novel human prolyl 4-hydroxylases
07/31/2003WO2002088357A3 84242, 8035, 55304, 52999, and 21999, novel human proteins and methods of use thereof
07/31/2003WO2002086123A3 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
07/31/2003WO2002083893A3 Isolation of dna molecules using mercapto-aryl ligands
07/31/2003WO2002081667A3 Ligases
07/31/2003WO2002072886A3 Complex element micro-array and methods of use
07/31/2003WO2002070707A3 Novel gpcr-like proteins and nucleic acids encoding same
07/31/2003WO2002068464A3 Fusion protein for blocking the hiv nef protein
07/31/2003WO2002063000A3 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same
07/31/2003WO2002060941A3 Fluorescent proteins
07/31/2003WO2002060936A3 Vaccine and compositions for the prevention and treatment of neisserial infections
07/31/2003WO2002059292A3 Functional balanced-lethal host-vector systems
07/31/2003WO2002059148A3 A method for identification, isolation and production of antigens to a specific pathogen
07/31/2003WO2002048362A3 Embryogenesis associated proteins
07/31/2003WO2002046421A3 Methods and compositions for analysis of m3 muscarinic acetylchloine receptors
07/31/2003WO2002044386A3 Targeted regulation of gene expression
07/31/2003WO2002042458A3 G protein coupled receptors
07/31/2003WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/31/2003WO2002034886A3 Isolation of binding proteins with high affinity to ligands
07/31/2003WO2002033041A3 Production of bovine lysozyme by plant viral vectors
07/31/2003WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
07/31/2003WO2002027005A3 Enhanced transfection system
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
07/31/2003WO2002024897A3 Conditionally replicating viral vectors and their use
07/31/2003WO2002022884A3 Microarrayed organization of transcription factor target genes
07/31/2003WO2002020847A3 Gene and sequence variation associated with lipid disorder
07/31/2003WO2002019814A3 Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety
07/31/2003WO2002018659A3 Method for determining alleles
07/31/2003WO2002018548A3 Tyrosine hydroxylase 5' control elements and uses thereof
07/31/2003WO2002018444A3 Erbb4 antagonists
07/31/2003WO2002012286A3 Stress proteins and peptides and methods of use thereof
07/31/2003WO2002010450A3 Replicable probe array
07/31/2003WO2002008949A3 Methods and systems for evaluating a matching between measured data and standards
07/31/2003WO2002004489A3 Polymorphic kinase anchor proteins and nucleic acids encoding the same
07/31/2003WO2001096870A3 Immunoassays for anti-hcv antibodies
07/31/2003WO2001094634A3 Methods and devices for multiplexing amplification reactions
07/31/2003WO2001092990A3 Structure-based methods for assessing amino acid variances
07/31/2003WO2001085912A3 Presenilin enhancers
07/31/2003WO2001080902A8 A particulate complex for administering nucleic acid into a cell
07/31/2003WO2001059098A9 Method for purifying nucleic acids
07/31/2003US20030145357 Rice alpha-amylase transcriptional enhancers
07/31/2003US20030145355 Methods of commercial production and extraction of protein from seed
07/31/2003US20030145354 Genetic engineered DNA comprising regulatory sequences of plant cell promoters linked DNA sequences that code for proteins or fragments that suppress endogenous gene expression transferase enzymes; agriculture
07/31/2003US20030145353 Polynucleotide comprising chimera genes linked to regulatory sequences that code for glycogenin, used for transforming cells and regenerating plants; genetic engineering
07/31/2003US20030145352 Nucleic acid molecules from rice and their use for the production of modified starch
07/31/2003US20030145350 Method for increasing the content of fatty acids in plants and micro-organisms
07/31/2003US20030145349 Plant transcription coactivators with histone acetyl transferase activity
07/31/2003US20030145348 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
07/31/2003US20030145347 Grain processing method and transgenic plants useful therein
07/31/2003US20030145346 Method of increasing expression of heterologous proteins in plants
07/31/2003US20030145345 LexA DNA binding domain optimized for arabidopsis species
07/31/2003US20030145344 Gene expression in plants; gene coding matallothionein; genomic library; transformed plant cell
07/31/2003US20030145343 Transgenic animals expressing human p25
07/31/2003US20030145342 Activation; transgenic rodent; genetic engineering
07/31/2003US20030145341 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
07/31/2003US20030145340 Ballistic transformation of C. elegans
07/31/2003US20030145339 Peptide production
07/31/2003US20030144500 Mutation detection method
07/31/2003US20030144497 Novel human transferase proteins and polynucleotides encoding the same
07/31/2003US20030144495 Drosophila recombination-associated protein and methods for use
07/31/2003US20030144494 Using polypeptide; incubation, calibration drug
07/31/2003US20030144492 Anticancer agents; central nervous system disorders; antiinflammatory agents
07/31/2003US20030144486 Monoclonal human natural antibodies
07/31/2003US20030144485 Monoclonal human natural antibodies
07/31/2003US20030144482 Diagnosis of skin cancer; vaccine
07/31/2003US20030144480 Genetic engineering; medical diagnosis
07/31/2003US20030144476 Genetic engineered polypeptide; medical diagnosis
07/31/2003US20030144475 Human protein and cdna
07/31/2003US20030144474 T cell receptor and a biologically active polypeptide with different recognition biding sites connected by a peptide linker; designed to redirect the immune system against various diseases
07/31/2003US20030144360 Synthetic bile acid receptor/ farnesoid x-activated receptor (bar/fxr) ligands agn 29 and agn 31 used as anticholesterol agents
07/31/2003US20030144242 Antisense modulation of MEKK4 expression
07/31/2003US20030144241 Antisense modulation of Smad6 expression
07/31/2003US20030144240 Antisense strategy to modulate estrogen receptor response (ER alpha and/or ER beta)
07/31/2003US20030144239 Expression system
07/31/2003US20030144233 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
07/31/2003US20030144232 Expression system
07/31/2003US20030144230 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation
07/31/2003US20030144229 Multiple CpG oligodeoxynucleotides and their use to induce an immune response
07/31/2003US20030144226 Drug screening for an antiviral agent, viricides; genetic engineering
07/31/2003US20030144225 A nucleic acid hybrids for inhibiting gene expression, antiinflammation to treat infections, suppress HIV infection
07/31/2003US20030144224 Antisense modulation of B-cell associated protein expression
07/31/2003US20030144223 Antisense modulation of connective tissue growth factor expression
07/31/2003US20030144221 Antisense modulation of BCL2-associated X protein expression
07/31/2003US20030144211 Inhibit leukocyte adhesion to endothelium or to platelets
07/31/2003US20030144210 Treatment of neurologic and psychiatric disorders
07/31/2003US20030144209 Bone anabolic agents for the treatment of bone disease
07/31/2003US20030144200 Novel forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
07/31/2003US20030144199 Modified ciliary neurotrophic factor, method of making and methods of use thereof
07/31/2003US20030144197 Autologous growth factor cocktail composition, method of production and use
07/31/2003US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica)
07/31/2003US20030144191 Polynucleotide encoding a novel TRP channel family member, TRP-PLIK2, and splice variants thereof
07/31/2003US20030144188 Androgen regulated nucleic acid molecules and encoded proteins
07/31/2003US20030144187 Comprising an osteoprotegerin polypeptide and an immunoglobulin FC region; treatment of bone disorders
1 ... 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 ... 4023